Pharmacists in Bellefonte, Pennsylvania


13 Pharmacists found in Bellefonte
female pharmacist

Amanda L Romig, RPH


Pharmacist
105 N Allegheny St, Bellefonte, PA 16823
814-355-3225     814-355-8547

male pharmacist

Andrew P Garofoli, RPH


Pharmacist
170 Buckaroo Ln, Bellefonte, PA 16823
814-355-2429     814-355-2506

female pharmacist

Anna Mcdermott, PHARMD


Pharmacist
502 E Curtin St, Bellefonte, PA 16823
814-553-2210    



female pharmacist

Aya Samra


Pharmacist
170 Buckaroo Ln, Bellefonte, PA 16823
814-355-2429    

female pharmacist

Dr. Briana Hunter, PHARMD


Pharmacist
821 E Bishop St, Bellefonte, PA 16823
814-355-1548    

male pharmacist

Colt J Edwards


Pharmacist
821 E Bishop St, Bellefonte, PA 16823
814-355-1548    

male pharmacist

Mr. David Andrew Montgomery, RPH.


Pharmacist
114 N Allegheny St, Bellefonte, PA 16823
814-359-2914     814-355-7628

female pharmacist

Elena Marines, PHARMD


Pharmacist - Pharmacotherapy
819 E Bishop St, Bellefonte, PA 16823
814-231-6240    

female pharmacist

Jessica Elyse Beattie, PHARMD


Pharmacist
127 S Potter St, Bellefonte, PA 16823
814-355-8244    

male pharmacist

John Michael Luckovich, RPH


Pharmacist
105 N Allegheny St, Bellefonte, PA 16823
814-355-3225    

female pharmacist

Mrs. Lana Marie Eichenlaub, PHARM.D.,R.PH


Pharmacist
925 E Bishop St, Bellefonte, PA 16823
814-355-1548     814-355-2558

female pharmacist

Teresa Dunkle


Pharmacist
105 N Allegheny St, Bellefonte, PA 16823
815-355-3225    

female pharmacist

Vanessa Ann Kreashko, PHARMD


Pharmacist
821 E Bishop St, Bellefonte, PA 16823
814-355-1548    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.